• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

EQRx, Inc. - Common Stock (NQ:EQRX)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 1.760 (5)
Ask (Size) 2.800 (1)
Prev. Close 2.340
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
EQRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of EQRx, Inc. - EQRX
October 06, 2023
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
EQRX Shareholder Investigation: Robbins LLP Reminds Shareholders it is Investigating EQRx, Inc. on behalf of Shareholders
September 27, 2023
From Robbins LLP
Via Business Wire

Performance

More News

Read More
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Capri Holdings Limited (NYSE – CPRI), Avid® (Nasdaq - AVID), EQRx, Inc. (Nasdaq - EQRX)
August 10, 2023
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Earnings Outlook For EQRx ↗
May 05, 2023
Via Benzinga
News headline image
EQRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of EQRx, Inc. - EQRX
August 02, 2023
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
August 01, 2023
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
August 01, 2023
Via Benzinga
News headline image
Revolution Medicines To Acquire EQRx In All-Stock Transaction To Gain Over $1B In Additional Capital ↗
August 01, 2023
Via Benzinga
News headline image
Caterpillar, Oshkosh, AudioCodes And Other Big Stocks Moving Higher On Tuesday ↗
August 01, 2023
Via Benzinga
News headline image
EQRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of EQRx, Inc. Is Fair to Shareholders
August 01, 2023
From Halper Sadeh LLC
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
August 01, 2023
Via Benzinga
News headline image
Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1 Billion in Additional Capital
August 01, 2023
From Revolution Medicines, Inc.; EQRx, Inc.
Via GlobeNewswire
News headline image
Week In Review: BlissBio Announces Potential $2 Billion Deal With Eisai For HER2 ADC ↗
May 13, 2023
Via Talk Markets
News headline image
EQRx Announces Massive Strategic Reset, Slashes Pipeline & Workforce ↗
May 09, 2023
Via Benzinga
News headline image
EQRx Resets to Focus on Clinically Differentiated Medicines, Leveraging $1.3 Billion Cash Position; Reports First Quarter 2023 Financial Results
May 08, 2023
From EQRx, Inc.
Via GlobeNewswire
News headline image
EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023
April 27, 2023
From EQRx, Inc.
Via GlobeNewswire
News headline image
EQRx, Inc. (EQRX) Shareholder Investigation: Robbins LLP is Investigating EQRX, Inc. on behalf of Shareholders
April 21, 2023
From Robbins LLP
Via Business Wire
News headline image
EQRx Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Progress
February 23, 2023
From EQRx, Inc.
Via GlobeNewswire
News headline image
EQRx to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From EQRx, Inc.
Via GlobeNewswire
News headline image
EQRx Announces Acceptance of Marketing Authorization Application by the UK’s Medicines and Healthcare Products Regulatory Agency for Sugemalimab in Metastatic Non-small Cell Lung Cancer
December 19, 2022
From EQRx, Inc.
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
December 14, 2022
Via Benzinga
News headline image
EQRx Announces Acceptance of Marketing Authorization Application by the European Medicines Agency for Aumolertinib in EGFR-Mutated Non-small Cell Lung Cancer
December 02, 2022
From EQRx, Inc.
Via GlobeNewswire
News headline image
Week In Review: Insilico Signs Six-Drug Discovery Deal With Sanofi Worth Up To $1.2 Billion ↗
November 12, 2022
Via Talk Markets
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 11, 2022 ↗
November 11, 2022
Via Benzinga
News headline image
BP To Rally Around 22%? Plus This Analyst Predicts $47 For YETI ↗
November 11, 2022
Via Benzinga

Frequently Asked Questions

Is EQRx, Inc. - Common Stock publicly traded?
Yes, EQRx, Inc. - Common Stock is publicly traded.
What exchange does EQRx, Inc. - Common Stock trade on?
EQRx, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for EQRx, Inc. - Common Stock?
The ticker symbol for EQRx, Inc. - Common Stock is EQRX on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap